**MODEL-AD Webinar | March 24 at 3pm (EST)** Dr. Gregory Carter of the Model Organism Development and Evaluation for Late-onset Alzheimer?s Disease (MODEL-AD) consortium will be discussing the team's goals, including the development of new models based on recent human genetics, the alignment of AD pathophysiology in mouse models and human studies, the staging of disease progression, and preclinical testing based on translatable biomarkers. [Register for the upcoming MODEL-AD webinar] (https://us02web.zoom.us/webinar/register/WN_px-ve2PKQGGaxmbWaumlPg) [View past webinars](https://news.adknowledgeportal.org/webinars/) @AMPADDataReleaseUpdates